Results 21 to 30 of about 109,215 (254)
Etiology and Outcomes of Thrombotic Microangiopathies. [PDF]
BACKGROUND AND OBJECTIVES Thrombotic microangiopathies constitute a diagnostic and therapeutic challenge. Secondary thrombotic microangiopathies are less characterized than primary thrombotic microangiopathies (thrombotic thrombocytopenic purpura and ...
Bayer G +20 more
europepmc +2 more sources
Thrombotic microangiopathy in children [PDF]
The syndrome of thrombotic microangiopathy (TMA) is a clinical-pathological entity characterized by microangiopathic hemolytic anemia, thrombocytopenia, and end organ involvement. It comprises a spectrum of underlying etiologies that may differ in children and adults.
Lilian Monteiro P. Palma +4 more
openaire +3 more sources
Complement Activation and Thrombotic Microangiopathies. [PDF]
BACKGROUND AND OBJECTIVES Atypical hemolytic uremic syndrome is a form of thrombotic microangiopathy caused by dysregulation of the alternative complement pathway. There is evidence showing complement activation in other thrombotic microangiopathies. The
Palomo M +36 more
europepmc +2 more sources
Thrombotic microangiopathies are a group of clinical syndromes characterized by microangiopathic hemolytic anemia, thrombocytopenia and end-organ damage, which can compromise the central nervous system.
Xavier Merchán-del-Hierro +5 more
doaj +1 more source
Thrombotic Microangiopathies [PDF]
Thrombotic microangiopathy results from thrombotic occlusion of the microvasculature leading to fragmentation of red blood cells, profound thrombocytopenia, and a microangiopathic hemolytic anemia with elevation of lactate dehydrogenase and negative direct Coomb’s test.
Radhi, Mohamed, Carpenter, Shannon L.
openaire +2 more sources
Thrombotic thrombocytopenic purpura is a disease from the group of thrombotic microangiopathies, the early diagnosis of which is a real challenge in clinical practice.
А. R. Аvidzba +2 more
doaj +1 more source
Thrombotic microangiopathies postrenal transplantation
Aims: The aim of the study was to describe 12 cases of thrombotic microangiopathy (TMA) postrenal transplantation and study the causes, treatment, and outcomes.
Kartik Ganesh +5 more
doaj +1 more source
COVID-19 and Thrombotic Thrombocytopenic Purpura: A Case Report
Endothelial injury by toxins, drugs, immune complexes leads to activation of coagulation cascade and thrombosis, which result in platelet consumption and red blood cell injury. These thrombotic microangiopathies can potentially injure numerous organs and
Maryam Darnahal +3 more
doaj +1 more source
The thrombotic microangiopathies [PDF]
The term thrombotic microangiopathy (TMA) encompasses a group of conditions that are defined by, or result from, a similar histopathological lesion. Hemolytic uremic syndrome (HUS), thrombotic thrombocytopenic purpura (TTP), and several other conditions are associated with TMA.
Copelovitch, Lawrence +1 more
openaire +2 more sources
Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors : a single-institution experience [PDF]
Thrombotic microangiopathies are rare conditions characterized by microangiopathic hemolytic anemia, microthrombi, and multiorgan insult. The disorders, which include hemolytic uremic syndrome and thrombotic thrombocytopenic purpura, are often acute and ...
Catlow, Jamie +4 more
core +1 more source

